Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia

por Collette, Y, Prébet, T, Goubard, A, Adélaïde, J, Castellano, R, Carbuccia, N, Garnier, S, Guille, A, Arnoulet, C, Charbonier, A, Mozziconacci, M J, Birnbaum, D, Chaffanet, M, Vey, N
Publicado 2015